Back

Companion animals harbour globally circulating human-associated Klebsiella pneumoniae lineages and high-risk antimicrobial resistance clones

Fordham, S. M. E.; Sheridan, E.; Drobniewski, F.

2026-06-15 microbiology
10.64898/2026.06.13.732079 bioRxiv
Show abstract

Companion animals are increasingly recognised within One Health antimicrobial-resistance (AMR) surveillance, yet the global genomic structure of dog- and cat-associated Klebsiella pneumoniae remains poorly defined. We assembled a global dataset of 712 domestic dog- and cat-derived K. pneumoniae genomes to define lineage diversity, AMR burden, host-associated patterns and overlap with human-associated populations. Companion-animal isolates comprised 263 sequence types (STs), but recurrent high-risk lineages, including ST307, ST11, ST15 and ST147, were prominent. Among 706 isolates from 25 countries, extended-spectrum {beta}-lactamase (ESBL) and carbapenemase genes were widely distributed, detected in 303 (42.9%) and 98 (13.9%) isolates, respectively. Cat-derived isolates showed higher multidrug-resistance (MDR) prevalence than dog-derived isolates; 80.0% versus 56.3%, partly reflecting enrichment of epidemic clones, especially ST147. MDR was not confined to infection-associated samples, indicating that colonisation may represent an important reservoir state. Comparison with 38,106 human-associated K. pneumoniae isolates revealed extensive ST overlap, with 71.1% of companion-animal STs and 87.2% of companion-animal isolates belonging to STs also detected in humans. Focused recombination-filtered phylogenomics of ST147 identified a recent host-spanning MDR sub-lineage linking cat-, dog- and human-associated genomes. Together, these findings show that domestic dogs and cats are not epidemiologically separate from the wider K. pneumoniae AMR landscape, but harbour globally circulating human-associated lineages and high-risk AMR clones.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 4%
26.4%
2
Genome Medicine
183 papers in training set
Top 0.1%
12.4%
3
Microbial Genomics
225 papers in training set
Top 0.3%
11.8%
50% of probability mass above
4
The Lancet Infectious Diseases
73 papers in training set
Top 0.3%
4.0%
5
Nature Microbiology
155 papers in training set
Top 1%
3.2%
6
The Journal of Infectious Diseases
202 papers in training set
Top 1%
2.6%
7
mBio
833 papers in training set
Top 6%
2.6%
8
eLife
5828 papers in training set
Top 40%
2.4%
9
Scientific Reports
3612 papers in training set
Top 42%
2.4%
10
Journal of Infection
78 papers in training set
Top 0.4%
2.4%
11
npj Antimicrobials and Resistance
11 papers in training set
Top 0.1%
2.1%
12
Microbiology Spectrum
469 papers in training set
Top 7%
1.7%
13
PLOS Pathogens
820 papers in training set
Top 7%
1.3%
14
The Lancet Microbe
44 papers in training set
Top 0.5%
1.3%
15
Nature
645 papers in training set
Top 8%
1.1%
16
Journal of Antimicrobial Chemotherapy
46 papers in training set
Top 0.7%
1.1%
17
PLOS ONE
5266 papers in training set
Top 55%
1.1%
18
Science Advances
1243 papers in training set
Top 27%
1.1%
19
One Health
29 papers in training set
Top 0.5%
1.0%
20
Communications Biology
993 papers in training set
Top 25%
1.0%
21
Antimicrobial Agents and Chemotherapy
187 papers in training set
Top 2%
0.9%
22
Emerging Microbes & Infections
74 papers in training set
Top 1%
0.8%
23
Nature Medicine
125 papers in training set
Top 3%
0.8%
24
Frontiers in Microbiology
427 papers in training set
Top 9%
0.6%
25
Emerging Infectious Diseases
105 papers in training set
Top 2%
0.6%
26
mSystems
394 papers in training set
Top 7%
0.6%